FI961696L - Pyridatsinokinoliiniyhdisteitä - Google Patents

Pyridatsinokinoliiniyhdisteitä Download PDF

Info

Publication number: FI961696L
Authority: FI; Finland
Prior art keywords: pyridazinoquinoline; compounds; pyridazinoquinoline compounds
Prior art date: 1993-10-22

Application number

FI961696A

Other languages

English (en)

Swedish (sv)

Other versions

FI961696A0 (fi

FI113865B (fi

Inventor

Thomas Michael Bare

Richard Bruce Sparks

James Roy Empfield

Timothy Wayne Davenport

Jeffrey Alan Mckinney

Original Assignee

Zeneca Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-10-22

Filing date

1996-04-18

Publication date

1996-04-18

1993-10-22 Priority claimed from GB939321854A external-priority patent/GB9321854D0/en

1994-08-25 Priority claimed from GB9417171A external-priority patent/GB9417171D0/en

1996-04-18 Application filed by Zeneca Ltd filed Critical Zeneca Ltd

1996-04-18 Publication of FI961696L publication Critical patent/FI961696L/fi

1996-04-18 Publication of FI961696A0 publication Critical patent/FI961696A0/fi

1997-03-03 Priority to FI970907A priority Critical patent/FI114916B/fi

2004-06-30 Application granted granted Critical

2004-06-30 Publication of FI113865B publication Critical patent/FI113865B/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Quinoline Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Saccharide Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

FI961696A 1993-10-22 1996-04-18 Menetelmä 2-aryylisubstituoidut-4-hydroksi-1,2,5,10-tetrahydropyridatsino[4,5-b]-kinoliini-1,10-dionijohdannaisten valmistamiseksi, jotka ovat terapeuttisesti käyttökelpoisia aivojen iskeemisten sairauksien hoidossa FI113865B (fi)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
FI970907A FI114916B (fi)	1993-10-22	1997-03-03	Menetelmä 2-aryylisubstituoidut-4-hydroksi-1,2,5,10-tetrahydropyridatsino- [4,5-b]kinoliini-1,10-dionijohdannaisten valmistamiseksi, jotka ovat terapeuttisesti käyttökelpoisia aivojen iskeemisten sairauksien hoidossa

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB939321854A GB9321854D0 (en)	1993-10-22	1993-10-22	Pyridazino quinoline compounds
GB9417171A GB9417171D0 (en)	1994-08-25	1994-08-25	Pyridazino quinoline compounds
PCT/GB1994/002295 WO1995011244A1 (en)	1993-10-22	1994-10-20	Pyridazino quinoline compounds

Publications (3)

Publication Number	Publication Date
FI961696L true FI961696L (fi)	1996-04-18
FI961696A0 FI961696A0 (fi)	1996-04-18
FI113865B FI113865B (fi)	2004-06-30

Family

ID=26303731

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
FI961696A FI113865B (fi)	1993-10-22	1996-04-18	Menetelmä 2-aryylisubstituoidut-4-hydroksi-1,2,5,10-tetrahydropyridatsino[4,5-b]-kinoliini-1,10-dionijohdannaisten valmistamiseksi, jotka ovat terapeuttisesti käyttökelpoisia aivojen iskeemisten sairauksien hoidossa
FI970907A FI114916B (fi)	1993-10-22	1997-03-03	Menetelmä 2-aryylisubstituoidut-4-hydroksi-1,2,5,10-tetrahydropyridatsino- [4,5-b]kinoliini-1,10-dionijohdannaisten valmistamiseksi, jotka ovat terapeuttisesti käyttökelpoisia aivojen iskeemisten sairauksien hoidossa

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
FI970907A FI114916B (fi)	1993-10-22	1997-03-03	Menetelmä 2-aryylisubstituoidut-4-hydroksi-1,2,5,10-tetrahydropyridatsino- [4,5-b]kinoliini-1,10-dionijohdannaisten valmistamiseksi, jotka ovat terapeuttisesti käyttökelpoisia aivojen iskeemisten sairauksien hoidossa

Country Status (29)

Country	Link
US (3)	US5744471A (fi)
EP (2)	EP1004582B1 (fi)
JP (1)	JP3583132B2 (fi)
KR (1)	KR100261209B1 (fi)
CN (1)	CN1053189C (fi)
AT (2)	ATE198072T1 (fi)
AU (2)	AU688393B2 (fi)
CA (1)	CA2171332A1 (fi)
CZ (1)	CZ292311B6 (fi)
DE (2)	DE69426422T2 (fi)
DK (2)	DK1004582T3 (fi)
ES (2)	ES2241513T3 (fi)
FI (2)	FI113865B (fi)
GB (1)	GB9420590D0 (fi)
GR (1)	GR3035080T3 (fi)
HU (1)	HUT74161A (fi)
IL (1)	IL111266A (fi)
MY (2)	MY132875A (fi)
NO (1)	NO306995B1 (fi)
NZ (2)	NZ275472A (fi)
PL (1)	PL180679B1 (fi)
PT (2)	PT724583E (fi)
RU (1)	RU2168511C2 (fi)
SG (2)	SG92630A1 (fi)
SI (2)	SI1004582T1 (fi)
SK (1)	SK282491B6 (fi)
TW (1)	TW406082B (fi)
UA (1)	UA60291C2 (fi)
WO (1)	WO1995011244A1 (fi)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9420590D0 (en) *	1993-10-22	1994-11-30	Zeneca Ltd	Pyridazino quinoline compounds
US6214826B1 (en)	1994-11-12	2001-04-10	Zeneca Limited	Pyridazino quinoline compounds
GB9422894D0 (en) *	1994-11-12	1995-01-04	Zeneca Ltd	Pyridazino quinoline compounds
GB9507318D0 (en) *	1995-04-07	1995-05-31	Zeneca Ltd	Alpha substituted pyridazino quinoline compounds
ES2239632T3 (es) *	1999-12-23	2005-10-01	Astrazeneca Ab	Derivado de piridazino-quinolina y metodo para el tratamiento del dolor.
US6730675B2 (en)	1999-12-23	2004-05-04	Astrazeneca Ab	Compounds and methods for the treatment of pain
US20050124622A1 (en) *	1999-12-23	2005-06-09	Brown Dean G.	Compounds and methods for the treatment of pain
EE200200348A (et) *	1999-12-23	2003-08-15	Astrazeneca Ab	Ravimkoostis kasutamiseks valu ravis
JP2003519145A (ja) *	1999-12-23	2003-06-17	アストラゼネカ・アクチエボラーグ	痛みの処置のための化合物および方法
EP1577311A1 (en) *	1999-12-23	2005-09-21	AstraZeneca AB	Salts of a pyridazino aquinoline derivative and use for the treatment of pain
US20030176435A1 (en) *	2002-12-17	2003-09-18	Brown Dean Gordon	Compounds and methods for the treatment of pain
DE60026883T2 (de) *	1999-12-23	2006-11-23	Astrazeneca Ab	Methoden und zusammensetzungen zur behandlung von schmerzen
WO2001047925A1 (en) *	1999-12-23	2001-07-05	Astrazeneca Ab	Compounds and methods for the treatment of pain
US6943165B2 (en) *	1999-12-23	2005-09-13	Astrazeneca Ab	Compound and method for the treatment of pain
US6787547B2 (en)	1999-12-23	2004-09-07	Astrazeneca Ab	Compound and method for the treatment of pain
WO2001047524A1 (en) *	1999-12-23	2001-07-05	Astrazeneca Ab	Method and composition for the treatment of pain
US6403818B1 (en)	2000-02-28	2002-06-11	Eisai Co., Ltd.	Process for producing α-hydroxy-carbonyl compound
ATE334982T1 (de)	2000-09-29	2006-08-15	Astrazeneca Ab	7-chlor-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10-
ES2263661T3 (es) *	2000-09-29	2006-12-16	Astrazeneca Ab	1,2,5,10-tetrahidropiridazino(4,5-b)quinolin-1,10-dionas y su uso para el tratamiento del dolor.
WO2002026741A1 (en) *	2000-09-29	2002-04-04	Astrazeneca Ab	1,2,5,10-TETRAHYDROPYRIDAZINO[4,5-b]QUINOLINE-1,10-DIONES AND THEIR USE FOR THE TREATMENT OF PAIN
EP1325005A1 (en) *	2000-09-29	2003-07-09	AstraZeneca AB	1,2,5,10-tetrahydropyridazino 4,5-b]quinoline-1,10-diones and their use for the treatment of pain
NZ529966A (en)	2001-05-31	2004-11-26	Sanofi Synthelabo	Aminoquinoline and aminopyridine derivatives and their use as adenosine A3 ligands
US8592421B2 (en)	2003-08-04	2013-11-26	Valery Khazhmuratovich Zhilov	Cyclic bioisosters of purine system derivatives and a pharmaceutical composition based thereon
US7495103B2 (en)	2004-06-24	2009-02-24	Vertex Pharmaceuticals Incorporated	Modulators of ATP-binding cassette transporters
US8354427B2 (en)	2004-06-24	2013-01-15	Vertex Pharmaceutical Incorporated	Modulators of ATP-binding cassette transporters
EP1979367A2 (en) *	2005-12-24	2008-10-15	Vertex Pharmaceuticals Incorporated	Quinolin-4-one derivatives as modulators of abc transporters
CA2635581C (en)	2005-12-28	2017-02-28	Vertex Pharmaceuticals Incorporated	Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
US12458635B2 (en)	2008-08-13	2025-11-04	Vertex Pharmaceuticals Incorporated	Pharmaceutical composition and administrations thereof
US20100074949A1 (en)	2008-08-13	2010-03-25	William Rowe	Pharmaceutical composition and administration thereof
SMT201700593T1 (it)	2009-03-20	2018-03-08	Vertex Pharma	Procedimento per preparare modulatori di regolatore di conduttanza transmembrana di fibrosi cistica
US8802700B2 (en)	2010-12-10	2014-08-12	Vertex Pharmaceuticals Incorporated	Modulators of ATP-Binding Cassette transporters
JP2015511583A (ja)	2012-02-27	2015-04-20	バーテックスファーマシューティカルズインコーポレイテッドＶｅｒｔｅｘＰｈａｒｍａｃｅｕｔｉｃａｌｓＩｎｃｏｒｐｏｒａｔｅｄ	薬学的組成物およびその投与
CA2963945C (en)	2014-10-07	2023-01-10	Vertex Pharmaceuticals Incorporated	Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8814458D0 (en) *	1988-06-17	1988-07-20	Wyeth John & Brother Ltd	Heterocyclic compounds
GB9208511D0 (en) *	1991-05-09	1992-06-03	Ici Plc	Compounds
GB9109972D0 (en) *	1991-05-09	1991-07-03	Ici Plc	Therapeutic compounds
GB9420590D0 (en) *	1993-10-22	1994-11-30	Zeneca Ltd	Pyridazino quinoline compounds
GB9422894D0 (en) *	1994-11-12	1995-01-04	Zeneca Ltd	Pyridazino quinoline compounds
GB9507318D0 (en) *	1995-04-07	1995-05-31	Zeneca Ltd	Alpha substituted pyridazino quinoline compounds

1994
- 1994-10-12 GB GB9420590A patent/GB9420590D0/en active Pending
- 1994-10-12 IL IL11126694A patent/IL111266A/xx not_active IP Right Cessation
- 1994-10-20 DK DK00101917T patent/DK1004582T3/da active
- 1994-10-20 SI SI9430476T patent/SI1004582T1/xx unknown
- 1994-10-20 AT AT94930275T patent/ATE198072T1/de not_active IP Right Cessation
- 1994-10-20 JP JP51152195A patent/JP3583132B2/ja not_active Expired - Fee Related
- 1994-10-20 ES ES00101917T patent/ES2241513T3/es not_active Expired - Lifetime
- 1994-10-20 SG SG9900943A patent/SG92630A1/en unknown
- 1994-10-20 NZ NZ275472A patent/NZ275472A/en not_active IP Right Cessation
- 1994-10-20 KR KR1019960702011A patent/KR100261209B1/ko not_active Expired - Fee Related
- 1994-10-20 AU AU79440/94A patent/AU688393B2/en not_active Ceased
- 1994-10-20 CZ CZ19961138A patent/CZ292311B6/cs not_active IP Right Cessation
- 1994-10-20 CN CN94194578A patent/CN1053189C/zh not_active Expired - Fee Related
- 1994-10-20 CA CA002171332A patent/CA2171332A1/en not_active Abandoned
- 1994-10-20 DK DK94930275T patent/DK0724583T3/da active
- 1994-10-20 SI SI9430314T patent/SI0724583T1/xx unknown
- 1994-10-20 MY MYPI98002508A patent/MY132875A/en unknown
- 1994-10-20 US US08/637,641 patent/US5744471A/en not_active Expired - Fee Related
- 1994-10-20 MY MYPI94002796A patent/MY124316A/en unknown
- 1994-10-20 UA UA96041567A patent/UA60291C2/uk unknown
- 1994-10-20 AT AT00101917T patent/ATE295846T1/de not_active IP Right Cessation
- 1994-10-20 SK SK504-96A patent/SK282491B6/sk not_active IP Right Cessation
- 1994-10-20 WO PCT/GB1994/002295 patent/WO1995011244A1/en not_active Ceased
- 1994-10-20 DE DE69426422T patent/DE69426422T2/de not_active Expired - Fee Related
- 1994-10-20 SG SG1996007261A patent/SG59971A1/en unknown
- 1994-10-20 EP EP00101917A patent/EP1004582B1/en not_active Expired - Lifetime
- 1994-10-20 NZ NZ329303A patent/NZ329303A/xx not_active IP Right Cessation
- 1994-10-20 PL PL94314041A patent/PL180679B1/pl not_active IP Right Cessation
- 1994-10-20 PT PT94930275T patent/PT724583E/pt unknown
- 1994-10-20 PT PT00101917T patent/PT1004582E/pt unknown
- 1994-10-20 DE DE69434380T patent/DE69434380T2/de not_active Expired - Fee Related
- 1994-10-20 RU RU96109470/04A patent/RU2168511C2/ru not_active IP Right Cessation
- 1994-10-20 ES ES94930275T patent/ES2154686T3/es not_active Expired - Lifetime
- 1994-10-20 HU HU9600889A patent/HUT74161A/hu unknown
- 1994-10-20 EP EP94930275A patent/EP0724583B1/en not_active Expired - Lifetime
- 1994-11-18 TW TW083110721A patent/TW406082B/zh not_active IP Right Cessation
1996
- 1996-04-18 FI FI961696A patent/FI113865B/fi active
- 1996-04-19 NO NO961584A patent/NO306995B1/no not_active IP Right Cessation
1997
- 1997-03-03 FI FI970907A patent/FI114916B/fi active IP Right Grant
1998
- 1998-03-19 US US09/044,109 patent/US6232313B1/en not_active Expired - Fee Related
- 1998-05-27 AU AU68999/98A patent/AU721139B2/en not_active Ceased
1999
- 1999-12-06 US US09/455,096 patent/US6103721A/en not_active Expired - Fee Related
2000
- 2000-12-14 GR GR20000402690T patent/GR3035080T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
NO961584D0 (no)	1996-04-19
EP1004582A3 (en)	2000-08-30
HK1013997A1 (en)	1999-09-17
PL180679B1 (en)	2001-03-30
DE69434380D1 (de)	2005-06-23
GR3035080T3 (en)	2001-03-30
AU721139B2 (en)	2000-06-22
JP3583132B2 (ja)	2004-10-27
ES2154686T3 (es)	2001-04-16
RU2168511C2 (ru)	2001-06-10
FI114916B (fi)	2005-01-31
NO306995B1 (no)	2000-01-24
MY132875A (en)	2007-10-31
DE69426422D1 (de)	2001-01-18
US5744471A (en)	1998-04-28
NZ329303A (en)	2000-01-28
DK1004582T3 (da)	2005-08-15
PT724583E (pt)	2001-03-30
IL111266A0 (en)	1994-12-29
HUT74161A (en)	1996-11-28
KR100261209B1 (ko)	2000-09-01
CZ292311B6 (cs)	2003-09-17
NZ275472A (en)	1998-03-25
EP1004582A2 (en)	2000-05-31
CN1053189C (zh)	2000-06-07
AU688393B2 (en)	1998-03-12
FI961696A0 (fi)	1996-04-18
PT1004582E (pt)	2005-09-30
TW406082B (en)	2000-09-21
US6103721A (en)	2000-08-15
AU7944094A (en)	1995-05-08
UA60291C2 (uk)	2003-10-15
DK0724583T3 (da)	2001-03-05
MY124316A (en)	2006-06-30
EP0724583A1 (en)	1996-08-07
GB9420590D0 (en)	1994-11-30
SK50496A3 (en)	1997-03-05
SI1004582T1 (fi)	2005-08-31
AU6899998A (en)	1998-07-30
SG59971A1 (en)	1999-02-22
JPH09504519A (ja)	1997-05-06
US6232313B1 (en)	2001-05-15
EP0724583B1 (en)	2000-12-13
FI113865B (fi)	2004-06-30
FI970907A0 (fi)	1997-03-03
HU9600889D0 (en)	1996-06-28
ES2241513T3 (es)	2005-11-01
EP1004582B1 (en)	2005-05-18
DE69426422T2 (de)	2001-05-10
CZ113896A3 (en)	1996-09-11
SG92630A1 (en)	2002-11-19
DE69434380T2 (de)	2006-05-04
SK282491B6 (sk)	2002-02-05
CN1138332A (zh)	1996-12-18
PL314041A1 (en)	1996-08-05
IL111266A (en)	2002-03-10
CA2171332A1 (en)	1995-04-27
NO961584L (no)	1996-04-19
SI0724583T1 (en)	2001-04-30
ATE198072T1 (de)	2000-12-15
FI970907L (fi)	1997-03-03
WO1995011244A1 (en)	1995-04-27
ATE295846T1 (de)	2005-06-15

Publication	Publication Date	Title
FI954327L (fi)	1995-09-14	Atsasykloheksapeptidiyhdisteitä
BR1101108A (pt)	2000-03-14	Composto
FI961696L (fi)	1996-04-18	Pyridatsinokinoliiniyhdisteitä
FI945690L (fi)	1995-06-03	Substituoitu N-piperidino-3-pyratsolikarboksamidi
DE69431641D1 (de)	2002-12-12	Hörkapselnanordnung
DE69421035D1 (de)	1999-11-11	Ringoszillator
DE69429756D1 (de)	2002-03-14	Difibrillationsgerät
FI940154A7 (fi)	1994-07-16	Substituoidut dialkyylitioeetterit
FI954016A7 (fi)	1995-08-25	Uudet yhdisteet
ATA146094A (de)	1996-04-15	Windsichter
DK72693D0 (da)	1993-06-18	Compounds
DE59403503D1 (de)	1997-09-04	Substituierte 1-Aryltriazolinone
DK83493A (da)	1995-01-10	Svingningskompensator
DK124393D0 (da)	1993-11-03	Compounds
DE59309062D1 (de)	1998-11-19	Mischer-Trockner
FI956304L (fi)	1996-01-25	Substituoidut aryltioalkyylitiopyridiinit
FI954017L (fi)	1995-08-25	Uudet yhdisteet
BR9405830A (pt)	1996-01-16	Oxazois substituidos
FI962301A7 (fi)	1996-05-31	Substituoidut aminoalkyyliaminopyridiinit
FI1047U1 (fi)	1993-11-26	Matbesticksset
DK102693D0 (da)	1993-09-13	Novel compounds
FI934368A0 (fi)	1993-10-05	Dubbelregel foer foensterbaogar
SE9301252D0 (sv)	1993-04-16	Loestagbar traedurk foer baatar
SE9300970D0 (sv)	1993-03-24	Braensleinmatare foer fastbraenslepannor
ITRC930003A0 (it)	1993-03-29	Ecomat c